Clinical Trial Update: The Efficacy and Safety of Dabigatran Etexilate for the Treatment of Cerebral Venous Thrombosis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of dabigatran etexilate for the treatment of cerebral venous thrombosis, sponsored by Capital Medical Universit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Venous Thrombosis

Drugs mentioned

• Pradaxa (dabigatran etexilate)

Snippet

Sponsor: Capital Medical University | Conditions: Cerebral Venous Thrombosis | Phase 3 | Status: UNKNOWN